Dr Agarwals Eye Hospital Ltd.
| BSE: 526783 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE934C01018 |
| BSE 09:51 | 10 Jul | 220.00 |
0 (0.00%) |
OPEN
232.95 |
HIGH
232.95 |
LOW
213.00 |
| NSE 05:30 | 01 Jan | Dr Agarwals Eye Hospital Ltd |
| OPEN | 232.95 |
| PREVIOUS CLOSE | 220.00 |
| VOLUME | 55 |
| 52-Week high | 341.65 |
| 52-Week low | 169.20 |
| P/E | 7.56 |
| Mkt Cap.(Rs cr) | 103 |
| Buy Price | 220.05 |
| Buy Qty | 2.00 |
| Sell Price | 226.95 |
| Sell Qty | 1.00 |
Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Cipla | 645.95 | 7.15 | 1.12 | 12374.01 |
| Aurobindo Pharma | 824.15 | 11.50 | 1.42 | 12257.89 |
| Dr Reddy's Labs | 3941.85 | 45.65 | 1.17 | 11850.40 |
| Lupin | 872.15 | 5.20 | 0.60 | 11356.32 |
| Sun Pharma.Inds. | 495.50 | 13.45 | 2.79 | 10303.21 |
| Apollo Hospitals | 1421.95 | 18.50 | 1.32 | 8336.66 |
| Cadila Health. | 359.75 | 3.75 | 1.05 | 6492.70 |
| Glenmark Pharma. | 437.30 | 5.55 | 1.29 | 6304.87 |
| Torrent Pharma. | 2389.00 | 25.70 | 1.09 | 5762.48 |
| Alkem Lab | 2430.05 | 7.50 | 0.31 | 5714.09 |
| Divi's Lab. | 2205.65 | 30.00 | 1.38 | 4879.66 |
| Alembic Pharma | 945.65 | 12.20 | 1.31 | 4132.55 |
| Abbott India | 15626.55 | 73.05 | 0.47 | 3678.60 |
| Piramal Enterp. | 1463.70 | 17.30 | 1.20 | 3671.40 |
| Ipca Labs. | 1647.40 | 1.80 | 0.11 | 3605.66 |
| Jubilant Life | 714.00 | 5.45 | 0.77 | 3438.61 |
| Glaxosmi. Pharma | 1479.00 | 4.20 | 0.28 | 3224.68 |
| Sanofi India | 7648.30 | 54.15 | 0.71 | 3070.60 |
| Laurus Labs | 576.70 | 4.90 | 0.86 | 2797.34 |
| Nectar Lifesci. | 22.60 | 0.60 | 2.73 | 2784.93 |
Quick Links for Dr Agarwals Eye Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
